Topic: Panel Discussion on Section 101 Patent Eligibility
Moderated by Timothy Loomis, Vice President and Chief Patent Counsel for Qualcomm
This evening promises a lively and enlightening discussion by a panel of in-house and outside patent counsel regarding one of the most active and important topics of recent decisions by the Federal Circuit and the Supreme Court.
Panelists include: Phil Makrogiannis, Division Lead IP Counsel, Thermo Fisher Scientific and Michael L. Fuller, Partner, Knobbe Martens
Date: Thursday, November 20, 6:00 pm
About our moderator:
Managing the Patent Group with over 200 employees; advising senior executives on intellectual property matters; assisting general legal in negotiating, drafting and analyzing license and other agreements; performing M&A due diligence and integration planning; assisting with planning for a major corporate reorganization; managing outside counsel; managing defensive side of a corporate patent litigation; analyzing risk to licensing revenue of joining industry consortia and of including open source code in product releases; and screening candidates for employment.
About our panelists:
Phil Makrogiannis is Division Lead IP Counsel for the Life Sciences Division of Life Technologies Corporation, a $4B company in biotechnology. Life Technologies sells instruments and reagents to analyze cells, proteins, and DNA. The Life Sciences Division represents $1.5B in sales and $1B in profit based on the predominance of patent protected products. Phil leads a group of 12 patent attorneys and patent agents that support the IP needs for this business. Phil is active in legislative patent reform. He has been with the company for 11 years, through the acquisition of Applied Biosystems, Inc. by Invitrogen Corporation. Phil received his J.D. from U.C. Berkeley Boalt School of Law in 1999. Finnegan Henderson hired him in their newly minted Palo Alto, CA office which serviced clients in Silicon Valley during the dot.com days. Phil’s clients came from a variety of industries, including medical device, specialty chemicals, semiconductor, pharmaceuticals, and consumer electronics. At the firm, Phil specialized in IP due diligence and lectured at the University of Washington School of Law on the topic. Phil’s technical background is in Chemical Engineering. He received his B.S. from UCLA after which he worked as a process engineer for Exxon.
Mike’s practice includes patent prosecution, strategic planning and counsel relating to infringement and licensing issues, and intellectual property due diligence studies and related negotiations for mergers and acquisitions. Mike also routinely practices in contentious matters at the USPTO, and is currently overseeing several inter partes reviews (IPRs) and ex parte patent re-examinations on behalf of his clients.